Home › Core › ISCC-IDs › 28CrY6Jzu6QAP

View ISCC-ID

Core Data

28CrY6Jzu6QAP
ISCC-ID - digital asset identifier
CCN5am9N9kWzS-CTLdmVqmdwU1C-CDih8whK1hRWG-CRixLSsTaM9sN
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

an a2aadenosine receptor agonist atl313 reduces inflammation and improves survival in murine sepsis models

Ledger Reference

coblo
Source Ledger/Blockchain
468977
N-th ISCC Decleration on source ledger
2d0ffaefddc628d48beb13c6f28b3b8ee7ed6d89351b2a5ea3e3c414172e90d6
Hash of block that includes the ISCC-DECLARATION
d4bc67daf5ed0154a197d8f6e2150ea02e8f3ac5c7d5da9db6701dcea7365bba
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "An A2Aadenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Christopher C Moore", "@type": "Person"}, {"name": "Edward N Martin", "@type": "Person"}, {"name": "Grace H Lee", "@type": "Person"}, {"name": "Tom Obrig", "@type": "Person"}, {"name": "Joel Linden", "@type": "Person"}, {"name": "W Michael Scheld", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/1471-2334-8-141", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1186/1471-2334-8-141", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCN5am9N9kWzS-CTLdmVqmdwU1C-CDih8whK1hRWG-CRixLSsTaM9sN", "propertyID": "ISCC"}], "datePublished": "2008-10-20"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close